Özet:

Purpose: The purpose of this research is to evaluate treatment efficacy of methylphenidate, atomoxetine and combined therapy in attention deficit/hyperactivity disorder. Materials and Methods: For this purpose, decrease in attention deficit/hyperactivity disorder symptoms were evaluated before treatment and at the end of the first year in treatment with Conner’s Parent Rating Scale in three groups named Methylphenidate, Atomoxetine and Combined Therapy. 104 cases were included in the study. There were 82 cases (78.8%) in the Methylphenidate group, 14 cases (13.5%) in the Atomoxetine group and 8 cases (7.7%) in the Combined Therapy group. Results: In all three treatment groups, all of the Conner’s subcategories improved in scores, but the reduction in scores was significant only in the Methylphenidate group. The decrease in Conner’s subcategory scores was not significant when compared between the groups. Conclusions: All  of the drug treatments improved in symptoms of Attention Deficit/Hyperactivity Disorder but prospective studies are needed with large samples and equally distributed in drug groups in order to better understand the differences in effectiveness between them.

Anahtar Kelimeler: